News and Events

RECOVER Research Awards

RECOVER has awarded over $37 million in funding to more than 40 pathobiology studies that will further our understanding of how COVID affects different body tissues and organs.

R3 Seminar Recap: Clinical Spectrum of PASC: Focus on Mental Health

During the August 9th RECOVER Research Review (R3) Seminar, researchers presented the effects of COVID-19 on mental health in both adults and children, including brain changes and mental health issues. Presenters discussed what is known about these effects and how COVID-19 can cause mental health problems.

Duke Selected as RECOVER Clinical Trials Data Coordinating Center

The Duke Clinical Research Institute (DCRI) will oversee RECOVER’s efforts to find safe and effective treatments for Long COVID symptoms.

R3 Seminar Recap: Clinical Spectrum of PASC: Sex Differences in PASC

During the July 26th RECOVER Research Review (R3) Seminar, researchers presented on sex-specific differences in how people experience COVID-19 and PASC. Presenters discussed the impact of COVID-19 on gynecologic health, male infertility, hormones, sexual dysfunction, and the placenta.

R3 Seminar Recap: Clinical Spectrum of PASC: Focus on Metabolism and Gastrointestinal Function

During the July 12th RECOVER Research Review (R3) Seminar, researchers presented on metabolism and gastrointestinal function in PASC. The seminar explored what is known about this topic, the gaps in our knowledge, and how RECOVER will contribute to filling these gaps.

R3 Seminar Recap: Clinical Spectrum of PASC: Focus on Cardio-Pulmonary Function

During the June 28th RECOVER Research Review (R3) Seminar, researchers presented cardiopulmonary functions in PASC. Presenters explored what is known about cardiac function in PASC patients, the gaps in our knowledge, and how RECOVER will contribute to filling these knowledge gaps.

R3 Seminar Recap: Clinical Spectrum of PASC: Focus on Neuro-cognitive Function

During the June 14th RECOVER Research Review (R3) Seminar, researchers presented on the clinical spectrum of PASC with a focus on neurocognitive function. Presenters discussed the current understanding of neurocognitive function in PASC patients, the gaps in our knowledge, and how RECOVER will contribute to filling these knowledge gaps.

NIH Director’s Blog: Using AI to Advance Understanding of Long COVID Syndrome

NIH Director Lawrence Tabak, DDS, PhD, describes how artificial intelligence (AI) can help us learn why some people are more likely to have Long COVID.